HomeTrading IdeasUS Dollar Weakness Persists...

US Dollar Weakness Persists as Markets Brace for PCE Data

Yesterday was once again about broad weakness, with all majors and indexes profiting from the flash sale.

US Indices are loving this with the coming real closing at its record highs!

The broke new lows and pretty much all asset classes except for cryptocurrencies had a positive day – Cryptos seem to still be consolidating, waiting for news to breakout on any side.

The fact that is staying above the $100,000 mark still shows strength in the market, however, crypto aficionados are still waiting for an and altcoin rally.

In commodities, even despite de positive mood, is unchanged and trading above its $3,300 key pivot, found some relief after consecutive correction days and most less commonly traded commodities are up on the session except for and .

Alternative precious metals are finding continuous demand with and performing well in the past few weeks, with both metals up more than 6% on the session, and even and appreciating beyond 1.5%.

Daily Cross-Asset Performance

Cross-Asset Daily Performance, June 26, 2025 – Source: TradingView

A Picture of Performance for Major CurrenciesPerformance of Major Currencies

Currency Performance, June 26 – Source: OANDA Labs

All majors are leading against the US Dollar with the seeing newfound strength – It seems that tides are changing for the US’s neighbour, as the Loonie was the leader without much changing on the geopolitical side – traders are preparing for the CAD release today morning.

As a matter of fact, the Dollar Index just broke its 2025 lows, and except for a very rough session, the dollar found some relief throughout the end of the session with some position covering and mean reversion for today’s data.

For the rest of the majors, the is the lagger though still up 0.33% against the Greenback – only the is losing against its Northern neighbor, as the Banxico (Bank of Mexico) just cut their interest rates by 50 bps.

A Look at Economic Data Economic Calendar

MarketPulse Economic Calendar

The overnight and today’s sessions are promised to be full of releases, with the week having seen only a few key economic releases until now.

Key events comprise: Fed’s (very influent in the FED), Canadian GDP (exp unchanged), (exp + 0.1%) and later in the day markets will see the release of the US results (16:30), which might be a big mover if there’s any bad surprise.

Also do not forget the Japanese and release tonight between 19:00 and 19:30.

Safe Trades!

Most Popular

More from Author

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Read Now

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...